Announcement
04 Nov 2021
On 4 November 2021, the EIB provided financing worth EUR 20 million (USD 23 million) to French company Stilla Technologies to support the development of next-generation genetic tests.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
04 Nov 2021
Revocation date:
No revocation date
Updated: 04 Nov 2021
State loan
In force
The EIB's EUR 20 million loan (approx. USD 23 million) to Stilla Technologies was backed by a guarantee from the Pan-European Guarantee Fund (EGF, see related state act).
The EGF was created in April ...
Sign in to see more
Updated: 04 Nov 2021
State loan
In force
On 04 November 2021, the European Investment Bank (EIB) and French company Stilla Technologies Sas signed an agreement worth EUR 20 million (approx. USD 23 million) to support Stilla Technologies in t...
Sign in to see more
Related State Acts
Threads
See all
This state act is not part of any Thread yet.